Craven House Capital plc (CRV) USD1

Sell:$0.13Buy:$0.13No change

Prices delayed by at least 15 minutes
Sell:$0.13
Buy:$0.13
Change:No change
Prices delayed by at least 15 minutes
Sell:$0.13
Buy:$0.13
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Craven House Capital Plc is a United Kingdom-based investment company. The Company’s investment policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-commerce sector. Its investment portfolio comprises minority shareholdings in a number of Swedish-managed businesses operating in the eCommerce and pharmaceutical sector. Its investment portfolio comprises BioVitos Medical Ltd, RoseMonkey Ltd, Garimon Limited, Stormfjord Limited, BioVitos Medical Limited, Rosedog Limited, and Honeydog Limited. Garimon Limited’s assets comprise ownership of the domain www.magazinos.com, a platform for digital magazine distribution. BioVitos Medical Limited has a license to market a patented heart drug, Succifer. Rosedog Limited is the owner of TV Zinos (www.tvzinos.com), a Website which offers a number of free-to-view television channels. The Company’s investment manager is Desmond Holdings Ltd.

Key people

Tamra Spink
Company Secretary
Balbir S. Bindra
Non-Executive Director
Calum Peter Morrison
Non-Executive Director
Mark Joseph Pajak
Non-Executive Director
Click to see more

Key facts

  • EPIC
    CRV
  • Location
    United Kingdom
  • Sector
    Financial
  • Industry
    Misc. Financial Services
  • ISIN
    GB00BD4FQ360
  • Market cap
    $482,949.00
  • Employees
    0
  • Shares in issue
    3.86m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.